You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hematopoietic Progenitor Cell Transplantation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sickle Cell Disease Trial in Memphis (hydroxyurea, azathioprine, alemtuzumab, thioptepa, low dose total body irradiation and

Recruiting
  • Sickle Cell Disease
  • hydroxyurea, azathioprine, alemtuzumab, thioptepa, low dose total body irradiation and sirolimus
  • hydroxyurea, azathioprine, alemtuzumab, thiotepa, plerixafor, low dose total body irradiation, cyclophosphamide and sirolimus
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
May 5, 2022

Congenital Hemolytic Anemia, Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Peripheral

Recruiting
  • Congenital Hemolytic Anemia
  • Sickle Cell Disease
  • Peripheral blood hematopoietic progenitor cell (PBPC) transplant
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)

Completed
Has Results
  • Leukemia
  • Lymphoma
  • Total Lymphoid Irradiation
  • +10 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 28, 2022

Lymphoma Trial in Madison (drug, radiation, biological, procedure)

Completed
Has Results
  • Lymphoma
  • Fludarabine Phosphate
  • +9 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Dec 7, 2021

Plasma Cell Myeloma Trial in Omaha (drug, procedure, biological)

Active, not recruiting
  • Plasma Cell Myeloma
  • Omaha, Nebraska
    University of Nebraska Medical Center
Nov 21, 2022

Sickle Cell Disease Trial in Los Angeles, Oakland (CRISPR_SCD001)

Not yet recruiting
  • Sickle Cell Disease
  • Los Angeles, California
  • +1 more
Apr 25, 2022

Leukemia, Myelodysplastic Syndrome Trial in New York (WT1-sensitized T cells)

Completed
  • Leukemia
  • Myelodysplastic Syndrome
  • WT1-sensitized T cells
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 1, 2021

Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete

Completed
Has Results
  • Myeloproliferative Disorders
  • +4 more
  • T-cell replete PBPC allograft
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 12, 2022

Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)

Active, not recruiting
  • Refractory Non Hodgkin Lymphoma
  • Relapsed Non Hodgkin Lymphoma
  • rituximab
  • +7 more
  • Sacramento, California
    University of California Davis
Nov 28, 2022

Epstein-Barr Virus Infections, Adenovirus, Cytomegalovirus Infections Trial in Milwaukee (Cytotoxic T Lymphocytes)

Completed
  • Epstein-Barr Virus Infections
  • +2 more
  • Cytotoxic T Lymphocytes
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Oct 21, 2021

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (procedure, drug, other)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)

Active, not recruiting
  • Plasma Cell Leukemia
  • +3 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Morgantown (Busulfan, Fludarabine)

Active, not recruiting
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • Morgantown, West Virginia
    West Virginia University Hospitals Mary Babb Randolph Cancer Cen
Apr 6, 2021

Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • +3 more
  • Allogeneic Bone Marrow Transplantation
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

Terminated
Has Results
  • Acute Biphenotypic Leukemia
  • +29 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 4, 2023

HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,

Recruiting
  • HIV Infection
  • +10 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • La Jolla, California
  • +3 more
Dec 7, 2022

Acute Myeloid Leukemia, Hematologic Malignancies, Acute Lymphocytic Leukemia Trial in Cleveland (radiation, drug, procedure,

Completed
  • Acute Myeloid Leukemia
  • +10 more
  • total marrow irradiation
  • +7 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Seidman Cancer Ce
May 5, 2021

Pediatric Patients, Any Type of Severe Combined Immunodeficiency (SCID), Partial HLA Incompatible Allogeneic Hematopoietic Stem

Recruiting
  • Pediatric Patients
  • +2 more
  • Human T Lymphoid Progenitor (HTLP) injection
  • Paris, Ile De France, France
    Unité d'Immunologie Hématologie Rhumatologie Pédiatrique (UIHR),
Apr 13, 2021

Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +14 more
  • radiation therapy
  • +8 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Oct 7, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +14 more
  • Aldesleukin
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Seattle

Recruiting
  • Acute Biphenotypic Leukemia
  • +5 more
  • Dilanubicel
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
May 11, 2022

Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial

Active, not recruiting
  • Acute Leukemia
  • +14 more
  • Duarte, California
    City of Hope Medical Center
Nov 18, 2022

Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)

Recruiting
  • Plasma Cell Myeloma
  • Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 27, 2022

Autologous Hematopoietic Stem Cell Transplant Recipient, Loss of Chromosome 17p, Plasma Cell Leukemia Trial in Duarte (drug,

Active, not recruiting
  • Autologous Hematopoietic Stem Cell Transplant Recipient
  • +4 more
  • Duarte, California
    City of Hope
Mar 17, 2022